# Positive and negative controls in an experiment ## Quick Answer - Select a positive control that reliably produces the expected effect and a negative control that reliably produces no effect, then run both alongside every experimental batch to validate assay performance. - Choose controls based on the specific assay type, the question being asked, and the known biology of the system, not on convenience or habit. - A control that fails to behave as expected invalidates that experimental run, and the results cannot be interpreted until the control problem is diagnosed and resolved. ## What Controls Do in an Experiment Controls are the reference points that let you distinguish the effect of your treatment from the effect of everything else happening in your system. Without them, you cannot know whether your measured outcome came from the variable you manipulated or from some unintended factor such as reagent degradation, contamination, instrument drift, or the biological variation of the specimens themselves. A positive control is a sample or treatment that you know will produce the expected effect. It confirms that your assay can detect the phenomenon you are studying. A negative control is a sample or treatment that you know will not produce the effect. It confirms that your assay does not produce the effect on its own, without the active ingredient or condition you are testing. The two controls answer different questions. The positive control asks whether your detection system works. The negative control asks whether your detection system stays quiet when it should. Both questions must be answered before you can trust the results from your experimental samples. Consider a cattle study where calves naturally infected with Anaplasma marginale were housed with tick-free calves to measure transmission by Rhipicephalus microplus ticks. The infected calves served as a positive control for infection status, and the tick-free calves served as negative controls for both infection and tick exposure. The researchers confirmed that all negative control calves became infected after cohousing, which validated that their detection methods, blood smears, PCR, and ELISA, could identify infection when it occurred. Without those controls, a negative result in the exposed calves would have been uninterpretable because you could not distinguish between no transmission and failed detection [1]. ## The Decision Framework for Selecting Controls Selecting controls is a design decision that happens before you collect data. The framework below walks through the questions you need to answer for each experiment. ### Step 1: Define the Expected Effect Write down exactly what outcome you expect to observe if your treatment works. This outcome must be measurable with your chosen assay. For example, if you are testing whether a new disinfectant kills bacteria on surfaces, the expected effect is a reduction in colony-forming units compared to an untreated surface. The expected effect must be specific enough that you can recognize it when it appears. Vague expectations produce vague controls. If you cannot state what a positive result looks like, you cannot choose a positive control that will produce it. ### Step 2: Identify the Assay Failure Modes List the ways your assay could fail. Common failure modes include reagents that have lost activity, instruments that are miscalibrated, contamination that produces false signals, and operator error in the procedure. Each failure mode has implications for control selection. A positive control that produces the expected effect rules out most assay failures. A negative control that stays quiet rules out contamination and background signal. Running both controls in every batch means that a failure in either control tells you which part of the system needs attention. ### Step 3: Match Controls to the Biological Question The correct control depends on what you are asking. In a study of emotional responses to visual stimuli, researchers used images from the International Affective Picture System to elicit specific emotions and compared patients with major depressive disorder to healthy controls. The healthy participants served as a comparison group that established the normal range of emotional response, and the stimulus categories served as positive and negative conditions for the emotions being studied [2]. In a meta-analysis of attentional bias in paranoia, the researchers compared response times to threat-related stimuli against neutral stimuli. The neutral stimuli functioned as a negative control condition, establishing the baseline response against which threat-related attentional bias was measured [3]. The principle transfers directly to farming and veterinary research. If you are testing a vaccine, the positive control is a group known to seroconvert, and the negative control is a group that receives a sham injection. If you are testing a feed additive, the positive control is a diet known to improve weight gain, and the negative control is the standard ration without the additive. ### Step 4: Consider the Cost and Availability of Controls Controls consume resources. Positive controls may require purchasing reference standards, maintaining known-infected animals, or synthesizing control compounds. Negative controls may require additional animals, additional plates, or additional field plots. The cost of controls must be weighed against the cost of an uninterpretable experiment. A single failed experiment that cannot be interpreted because controls were omitted costs more than the controls would have cost. Funding agencies expect this reasoning in grant applications, and reviewers routinely reject proposals that lack adequate controls [4]. ### Step 5: Document the Control Selection Rationale Write down why you chose each control. This documentation serves two purposes. First, it forces you to think through the logic before you start. Second, it provides the information needed for transparent reporting when you publish or share your results. Reporting guidelines available through the EQUATOR Network help researchers disclose their methods completely, including the controls used and how they were handled [5]. Complete reporting allows other researchers to evaluate whether your controls were adequate and to replicate your work. ## At a Glance: Control Selection by Assay Type | Assay Type | Positive Control Example | Negative Control Example | What Each Control Validates | | --- | --- | --- | --- | | PCR or qPCR | Amplification of a known target sequence | No-template reaction with water instead of DNA | Positive confirms primers and polymerase work, negative confirms no contamination in reagents | | ELISA or immunoassay | Sample known to contain the target antigen or antibody | Sample known to lack the target, processed identically | Positive confirms detection antibody binds, negative confirms no nonspecific binding | | Microbiological culture | Reference strain known to grow on the medium | Sterile medium incubated without inoculation | Positive confirms medium supports growth, negative confirms medium is sterile | | Animal challenge study | Animals known to develop disease after challenge | Animals housed without challenge or given sham treatment | Positive confirms challenge model works, negative confirms disease does not appear spontaneously | | Field trial of a treatment | Plot or group receiving a treatment with known efficacy | Plot or group receiving no treatment or standard practice | Positive confirms the measurement system detects the effect, negative establishes baseline conditions | ## Practical Implementation Steps ### Step 1: Build Controls into the Experimental Design Controls are not an afterthought. They belong in the design phase, before you order reagents, allocate animals, or prepare field plots. Write the control groups into your protocol and specify how many replicates each control receives. The number of control replicates matters. A single positive control well on a plate may not detect a problem that affects only part of the plate. A single negative control animal may not detect contamination that affects only one pen. The sample size for controls should follow the same statistical logic as the sample size for treatment groups, balancing the need for sensitivity against the cost of additional control units. ### Step 2: Process Controls Identically to Experimental Samples Controls must go through the same procedures as your experimental samples. A positive control that is handled differently, stored differently, or processed at a different time does not validate the assay for your experimental samples. This principle applies at every stage. If experimental samples are stored on ice for two hours before processing, controls should be stored the same way. If experimental animals are housed in a specific pen, control animals should experience the same housing conditions. The Anaplasma marginale transmission study housed infected and tick-free calves together in the same pens, ensuring that both groups experienced identical environmental conditions during the transmission period [1]. ### Step 3: Run Controls in Every Batch Assay performance drifts over time. Reagents degrade, instruments drift, and environmental conditions change. A positive control that worked last month may fail today. Running controls in every batch detects these changes when they happen. Batch-level controls also protect against operator variation. Different technicians may perform the same assay with slightly different technique. Controls run by each operator in each batch document whether the assay performs consistently across operators. ### Step 4: Establish Acceptance Criteria Before Running the Assay Decide in advance what control results will be considered acceptable. These criteria become your quality gates. If the positive control does not produce the expected effect, or if the negative control produces an unexpected effect, the batch fails and the experimental results cannot be interpreted. Acceptance criteria should be specific and measurable. For a qPCR assay, the positive control must amplify within a defined cycle threshold range, and the negative control must show no amplification. For an ELISA, the positive control must produce an absorbance above a defined threshold, and the negative control must produce absorbance below a defined threshold. ### Step 5: Record Control Results in the Laboratory Notebook Every control result belongs in the permanent record. Record the control identity, the expected result, the observed result, and the date and operator. This record allows you to track assay performance over time and to identify trends that may indicate developing problems. The NIH Data Management and Sharing Policy expects researchers to plan for the management of the data generated in their studies, including the documentation needed to make the data interpretable [6]. Control data are part of that documentation. Without control records, the experimental data cannot be evaluated by others. ## Records and Measurements ### What to Record for Each Control For each control in each batch, record the following information: - Control identity and type, positive or negative - Source of the control material, including lot numbers for reagents and identification numbers for animals - Expected result based on prior validation - Observed result with the specific measurement values - Date and time of the assay - Operator name - Instrument identification and calibration status - Any deviations from the standard protocol This level of detail supports troubleshooting when a control fails. If the positive control fails, you need to know which reagent lot was used, which instrument was used, and who performed the assay to identify the cause. ### Tracking Control Performance Over Time Control results collected across many batches form a performance history. Plotting control values over time reveals drift before it causes a batch failure. A positive control that is slowly trending toward the failure threshold signals that a reagent is degrading or an instrument is drifting. This tracking is standard practice in diagnostic laboratories and should be standard practice in research laboratories. The same logic applies to field studies. If you are running a multi-season field trial, control plots measured across seasons document environmental variation and help you interpret treatment effects. ### Using Control Data in Statistical Analysis Control data serve two statistical purposes. First, they establish the baseline against which treatment effects are measured. Second, they document that the assay was working during the experimental period. In the attentional bias meta-analysis, the comparison between threat-related and neutral stimuli depended on the neutral condition serving as a reliable baseline. The meta-analysis found a significant negative attentional bias with an average standardized effect size of 0.26, but the authors noted that the effect size may have been underestimated due to statistical limitations and that more data were needed to confirm moderator effects [3]. This caution reflects the reality that even well-controlled studies have limitations that must be acknowledged. ## Control Selection Workflow The following workflow summarizes the decision path from experimental question to validated control strategy. This sequence applies whether you are working with molecular assays, cell culture, animal models, or field trials. ```mermaid flowchart TD A[Define the biological question] --> B[State the expected effect of treatment] B --> C[Identify assay failure modes] C --> D[Select positive control that produces expected effect] C --> E[Select negative control that produces no effect] D --> F[Validate controls independently before use] E --> F F --> G[Set acceptance criteria before running assay] G --> H[Run controls in every batch with experimental samples] H --> I{Do controls meet acceptance criteria?} I -->|Yes| J[Interpret experimental results] I -->|No| K[Stop and troubleshoot the assay] K --> L[Identify root cause of control failure] L --> M[Correct the problem and repeat the batch] M --> H ``` The workflow begins with the biological question because the controls must match the specific effect you are studying. A control that works for one question may not work for another. The validation step is critical because a control is only useful if you have independently confirmed its expected behavior. The acceptance criteria must be set before the assay runs, not after the results are known. The loop back to troubleshooting reflects the reality that control failures happen and must be resolved before experimental results can be trusted. ## Common Failure Patterns ### Failure Pattern 1: The Positive Control Fails When the positive control does not produce the expected effect, the assay cannot detect the phenomenon of interest. Any negative result from experimental samples is uninterpretable because you cannot distinguish between no effect and failed detection. Common causes include degraded reagents, inactive enzyme preparations, expired antibodies, and incorrect storage conditions. The troubleshooting path starts with the most likely cause based on the assay type and the recent history of the reagents. ### Failure Pattern 2: The Negative Control Produces a Signal When the negative control produces an unexpected signal, something in the system is generating the effect without your treatment. This finding indicates contamination, nonspecific binding, or an unintended active ingredient in the system. In cell culture, a negative control that shows growth indicates contamination of the medium or the incubator. In PCR, a negative control that amplifies indicates contamination of the reagents or the workspace. In animal studies, a negative control that develops disease indicates that the disease is spreading through the facility or that the negative control animals were not truly negative. ### Failure Pattern 3: Controls Were Omitted Entirely The most common failure pattern is the absence of controls. This pattern usually results from pressure to save time or money, or from a mistaken belief that the assay is well established and does not need controls. The consequence is that the experimental results cannot be interpreted. A positive result could be a false positive from contamination. A negative result could be a false negative from failed detection. The experiment must be repeated with proper controls, which costs more than the controls would have cost in the first place. ### Failure Pattern 4: Controls Are Processed Differently Controls that are not processed identically to experimental samples create a false sense of security. The controls may pass while the experimental samples fail because the experimental samples experienced conditions the controls did not. This pattern is common when controls are run at a different time, by a different operator, or with different reagents than the experimental samples. The solution is to integrate controls into the same workflow as the experimental samples, at every stage of processing. ### Failure Pattern 5: Acceptance Criteria Are Applied Retrospectively When acceptance criteria are defined after seeing the results, the criteria can be adjusted to fit the data. This practice defeats the purpose of controls. A batch with a marginal positive control can be declared acceptable because the experimental results look interesting. The solution is to define acceptance criteria before running the assay and to apply them consistently. If the criteria need to be changed, the change must be documented and justified, and the affected data must be evaluated with the new criteria. ## Troubleshooting Control Failures ### Step 1: Confirm the Failure Is Real Before changing reagents or procedures, confirm that the control failure is reproducible. A single failed well may result from an air bubble, a pipetting error, or a defective tube. Repeat the control in the same batch or run a fresh batch to determine whether the failure persists. ### Step 2: Check the Obvious Causes First Start with the most likely causes based on the assay type. For molecular assays, check reagent expiration dates, storage temperatures, and instrument calibration. For cell-based assays, check medium sterility, incubator conditions, and cell viability. For animal studies, check housing conditions, feed, and water. ### Step 3: Review the Records The records you kept for each control become the troubleshooting tool. Compare the failed control to previous successful controls. Look for differences in reagent lot, operator, instrument, or processing conditions. A change in any of these variables may explain the failure. ### Step 4: Test One Variable at a Time When multiple variables changed between the last successful batch and the failed batch, test each variable individually. Change one variable at a time and run the control again. This approach identifies the specific cause without confounding multiple changes. ### Step 5: Document the Resolution When the cause is identified and corrected, record the problem and the solution in the laboratory notebook. This documentation prevents the same failure from recurring and provides a reference for future troubleshooting. ## Limitations of Controls ### Controls Validate the Assay, Not the Hypothesis A passing positive control and a clean negative control tell you that the assay worked. They do not tell you that your hypothesis is correct. The experimental samples still have to produce the expected results, and those results have to be statistically and biologically meaningful. ### Controls Cannot Detect All Problems Controls detect the problems they are designed to detect. A positive control that produces the expected effect confirms that the assay can detect that specific effect. It does not confirm that the assay can detect all effects or that the assay is sensitive enough to detect small effects. The attentional bias meta-analysis illustrates this limitation. The authors found a significant negative attentional bias but noted that the overall effect size was likely underestimated and that there were not enough studies to robustly examine moderators [3]. The controls in the individual studies validated the measurement of attentional bias, but the meta-analysis still had statistical limitations that affected the interpretation. ### Controls Are Only as Good as Their Validation A positive control is only positive if you have independently confirmed that it produces the expected effect. A negative control is only negative if you have independently confirmed that it does not produce the effect. This validation must happen before the control is used in experiments. For biological controls, validation requires knowing the true status of the control material. In the Anaplasma marginale study, the negative control calves were confirmed to be free of infection before the study began, and the positive control calves were confirmed to be naturally infected. This prior validation made the controls meaningful [1]. ### Controls Do Not Replace Replication Controls document that the assay works, but they do not provide the statistical power to detect treatment effects. The experimental samples still need adequate replication to support the conclusions. Sample size calculations should be based on the expected effect size and the variability of the measurement, not on the number of controls. ## Welfare and Safety Context ### Animal Welfare in Control Groups Control animals are subject to the same welfare obligations as treatment animals. Negative control animals may be housed with infected animals, as in the Anaplasma marginale transmission study, which means they may become infected during the study. This outcome must be anticipated and managed according to approved animal care protocols. The decision to use control animals that will experience disease or infection requires justification and oversight. Institutional animal care committees review these protocols to ensure that the scientific value justifies the welfare cost and that the animals receive appropriate care throughout the study. ### Biosafety Considerations Controls can introduce biological hazards into the laboratory. Positive controls for infectious agents contain the agent itself. Negative controls may become contaminated during processing. Both situations require adherence to biosafety practices. The WHO Laboratory Biosafety Manual provides guidance on the safe handling of biological materials, including the controls used in diagnostic and research assays [7]. The manual addresses facility design, personal protective equipment, and procedures for handling infectious materials safely. ### Sample Handling and Disposal Control materials must be handled and disposed of according to the same biosafety standards as experimental samples. A positive control containing an infectious agent must be inactivated or disposed of through the appropriate waste stream. A negative control that becomes contaminated must be treated as potentially infectious. These requirements apply to all biological samples, regardless of whether they are designated as controls or experimental samples. The designation does not change the biological risk. ## Professional Escalation Criteria ### When to Stop and Seek Help A single failed control in a single batch may be a random event that is resolved by repeating the assay. Repeated control failures indicate a systemic problem that requires investigation. The following situations warrant escalation to a supervisor, a laboratory manager, or a subject matter expert: - The positive control fails in two consecutive batches - The negative control produces a signal in two consecutive batches - Control results show a consistent trend toward the failure threshold - A control failure is accompanied by unexpected results in experimental samples - The cause of a control failure cannot be identified after basic troubleshooting ### What to Bring to the Escalation When escalating a control problem, bring the complete record of the affected batches. This record includes the control identities, the expected and observed results, the reagent lot numbers, the instrument calibration records, and the operator notes. The more complete the record, the faster the problem can be diagnosed. ### Publication and Reporting Responsibilities When control problems affect published results, the issues must be disclosed. The Committee on Publication Ethics Core Practices address the responsibilities of authors to report their methods accurately and to correct the record when errors are identified [8]. If a control failure is discovered after publication, the authors should contact the journal to discuss a correction or retraction. Authorship and data integrity are part of these responsibilities. Researchers who contributed to the design, execution, or interpretation of the controlled experiments should be credited appropriately, and the data should be reported completely and accurately [8]. ## Control Documentation Checklist | Documentation Item | Purpose | When to Record | | --- | --- | --- | | Control identity and type | Distinguishes positive from negative controls and links results to specific materials | At the time of assay setup | | Source and lot numbers | Enables tracing of reagent or material problems to specific batches | At the time of assay setup | | Expected result | Provides the reference for evaluating the observed result | Before running the assay | | Observed result with values | Documents the actual performance of the control | At the time of reading the assay | | Date, time, and operator | Supports troubleshooting and identifies operator-related variation | At the time of assay setup and reading | | Instrument and calibration status | Links control performance to instrument function | At the time of assay setup | | Protocol deviations | Documents any differences from the standard procedure | At the time the deviation occurs | | Acceptance criteria and pass or fail decision | Provides the quality gate for the batch | Before running the assay and at the time of reading | ## Building a Control Decision Matrix for Multi-Assay Studies Many experiments involve more than one assay or measurement method, and the control strategy must account for the relationships between them. A control that validates one assay may not validate another, and the failure of a single control can cascade through the interpretation of the entire study. A decision matrix provides a structured way to document which controls validate which assays and what actions to take when specific control failures occur. ### Step 1: Inventory Every Assay and Measurement in the Study Before selecting controls, list every assay and measurement method that will generate data in the study. This inventory includes the primary outcome assay, any confirmatory assays, and the ancillary measurements that support interpretation. Each assay has its own failure modes and requires its own controls. For example, the Anaplasma marginale transmission study used three detection methods to assess infection status in calves: blood smears, PCR, and ELISA [1]. Each method has different failure modes. Blood smears can fail due to poor staining or low parasitemia. PCR can fail due to inhibitors in the sample or degraded reagents. ELISA can fail due to nonspecific binding or expired antibodies. A single positive control animal confirmed infection status, but each assay still needed its own validation to confirm that the detection method worked. The inventory should also include the measurements that are not the primary outcome but are needed to interpret the results. If you are measuring weight gain in a feed trial, the scale calibration is a measurement system that needs validation. If you are measuring hormone levels, the assay kit controls are part of the measurement system. Every measurement that produces a number used in your conclusions belongs in the inventory. ### Step 2: Map Each Control to the Assays It Validates Once the assay inventory is complete, create a matrix that shows which controls validate which assays. The matrix has assays on one axis and controls on the other. Each cell indicates whether the control validates that assay, partially validates it, or does not apply. A single control can validate multiple assays if the assays measure the same biological phenomenon. In the Anaplasma marginale study, the infected calves served as positive controls for all three detection methods because all three methods were designed to detect the same infection [1]. The tick-free calves served as negative controls for all three methods because they were confirmed free of infection before the study began. However, a control that validates one assay may not validate another. A positive control for a PCR assay that detects a specific DNA sequence does not validate an ELISA that detects a protein. The two assays measure different molecules and have different failure modes. The matrix forces you to identify these gaps before the experiment begins. The matrix also identifies which assays lack controls. If an assay has no positive control, a negative result from that assay is uninterpretable. If an assay has no negative control, a positive result may be a false positive from contamination or nonspecific signal. The matrix makes these gaps visible during the design phase, when they can still be corrected. ### Step 3: Define the Decision Rules for Each Control-Assay Pair For each cell in the matrix, define what result constitutes a pass and what result constitutes a failure. These decision rules become the acceptance criteria for the study. They must be specific, measurable, and defined before the assay is run. For a PCR assay, the decision rule for the positive control might be amplification within a defined cycle threshold range. The decision rule for the negative control might be no amplification after a defined number of cycles. For an ELISA, the decision rule for the positive control might be absorbance above a defined threshold, and the decision rule for the negative control might be absorbance below a defined threshold. The decision rules should also specify what happens when a control fails. The default rule is that the batch fails and the experimental results cannot be interpreted. However, the matrix can specify exceptions. If the positive control for a confirmatory assay fails but the primary assay controls pass, the study may still be interpretable with limitations. These exceptions must be defined in advance, not after the results are known. ### Step 4: Identify Cross-Assay Dependencies Some assays depend on other assays for their interpretation. The failure of a control for one assay may affect the interpretation of another assay even if the second assay's controls pass. In the Anaplasma marginale study, the three detection methods were used together to determine infection status. If the PCR failed but the blood smear and ELISA passed, the infection status of the animals would still be interpretable because two methods confirmed the result. If the ELISA failed but the PCR and blood smear passed, the interpretation would also be possible. The cross-assay dependency meant that the study could tolerate the failure of one assay if the other two agreed [1]. The matrix should document these dependencies. For each assay, note which other assays can substitute for it if it fails. This documentation supports the decision to interpret results when one assay fails but others pass. It also identifies the assays that have no backup, which are the assays where a control failure is most costly. ### Step 5: Use the Matrix to Plan Troubleshooting When a control fails, the matrix guides the troubleshooting process. The matrix shows which assays are affected by the failure and which are not. It also shows which controls are affected and which are not. If the positive control for one assay fails but the positive controls for other assays pass, the problem is likely specific to that assay. The troubleshooting should focus on the reagents, instruments, and procedures specific to that assay. If multiple positive controls fail across different assays, the problem is likely systemic, affecting shared reagents, shared instruments, or the control material itself. The matrix also supports the documentation of troubleshooting outcomes. When a control failure is resolved, record the cause and the resolution in the matrix. This record builds a history of control performance that supports future troubleshooting and control selection. ### Step 6: Review and Update the Matrix Throughout the Study The control decision matrix is a living document. It should be reviewed when the protocol changes, when new assays are added, and when control failures reveal gaps in the strategy. The review should be scheduled at defined points in the study, such as after the pilot phase, after any protocol amendment, and at the end of the study. The review should also consider whether the controls remain valid over time. A positive control material that degrades over the course of a long study may stop producing the expected effect. The matrix should include the validation status of each control material and the schedule for revalidation. The NIH Data Management and Sharing Policy expects researchers to plan for the management of data generated in their studies, including the documentation needed to make the data interpretable [6]. The control decision matrix is part of that documentation. It provides the context needed to evaluate the control data and to interpret the experimental results. ## Implementing the Matrix in Practice ### Creating the Matrix Document The matrix can be created as a table in a laboratory notebook, a spreadsheet, or a project management document. The format should support the level of detail needed for the study. A simple study with one assay and two controls may only need a single table. A complex study with multiple assays and controls may need a separate document with multiple tables. The matrix should include the following information for each control-assay pair: - The assay name and the measurement method - The control identity and type - The expected result for the control in that assay - The acceptance criteria for the control in that assay - The action to take if the control fails - The cross-assay dependencies that affect interpretation ### Using the Matrix in Protocol Reviews The matrix should be reviewed before the study begins, as part of the protocol review. The review should confirm that every assay has appropriate controls, that the acceptance criteria are defined, and that the decision rules are consistent with the study objectives. The review should also confirm that the controls are feasible. A positive control that requires maintaining infected animals may not be feasible for a small study. The review should identify these feasibility issues and propose alternatives, such as using a reference standard or a commercially available control material. ### Using the Matrix in Data Analysis The matrix should be used during data analysis to determine which batches are interpretable and which are not. The analysis should start by checking the control results against the acceptance criteria. Batches that fail the control criteria are excluded from the analysis, and the reasons for exclusion are documented. The matrix also supports the interpretation of results when controls pass. The cross-assay dependencies documented in the matrix indicate which conclusions are supported by the data and which are not. If the primary assay controls pass but a confirmatory assay control fails, the conclusions may be supported with limitations that are documented in the analysis. ### Using the Matrix in Reporting The matrix should be included in the methods section of reports and publications. It provides the information needed for transparent reporting of the control strategy. Reporting guidelines available through the EQUATOR Network help researchers disclose their methods completely, including the controls used and how they were handled [5]. The matrix also supports the reporting of control results. Instead of listing each control result in the text, the matrix can be presented as a table that shows the control results for each assay. This presentation is more efficient and more informative than a narrative description. ## Common Mistakes in Multi-Assay Control Design ### Mistake 1: Assuming One Control Validates All Assays The most common mistake is assuming that a single positive control and a single negative control validate all assays in a study. This assumption is incorrect when the assays measure different molecules, use different detection principles, or have different failure modes. The solution is to create the assay inventory and map each control to the assays it validates. This mapping identifies the gaps where assays lack controls and forces the design of additional controls. ### Mistake 2: Ignoring Cross-Assay Dependencies A second mistake is ignoring the relationships between assays. If one assay fails, the interpretation of other assays may be affected even if their controls pass. The matrix documents these dependencies and supports the decision to interpret results when one assay fails. ### Mistake 3: Defining Acceptance Criteria After the Results Are Known A third mistake is defining acceptance criteria after seeing the results. This practice allows the criteria to be adjusted to fit the data, which defeats the purpose of controls. The matrix requires the acceptance criteria to be defined before the assay is run, which prevents this problem. ### Mistake 4: Failing to Update the Matrix When the Protocol Changes A fourth mistake is failing to update the matrix when the protocol changes. If a new assay is added, the matrix must be updated to include the controls for that assay. If a control material is changed, the matrix must be updated to reflect the new validation status. The matrix is a living document that must be maintained throughout the study. ## Records and Measurements for the Matrix ### What to Record for Each Control-Assay Pair For each control-assay pair in the matrix, record the following information: - The assay name and the specific measurement method - The control identity and type - The source of the control material, including lot numbers and animal identification numbers - The expected result based on prior validation - The acceptance criteria defined before the assay was run - The observed result with the specific measurement values - The pass or fail decision based on the acceptance criteria - The date and time of the assay - The operator name - Any deviations from the standard protocol This level of detail supports troubleshooting when a control fails. The records show which control failed, which assay was affected, and what the expected result should have been. ### Tracking Control Performance Across Assays Control results collected across many batches and assays form a performance history. Plotting control values over time reveals drift before it causes a batch failure. A positive control that is slowly trending toward the failure threshold signals that a reagent is degrading or an instrument is drifting. The matrix supports this tracking by organizing the control results by assay and by control. This organization makes it possible to compare control performance across batches and to identify trends that may indicate developing problems. ### Using the Matrix in Statistical Analysis The matrix supports the statistical analysis by identifying which batches are interpretable and which are not. Batches that fail the control criteria are excluded from the analysis, and the reasons for exclusion are documented. The matrix also supports the interpretation of results when controls pass by documenting the cross-assay dependencies that affect interpretation. The attentional bias meta-analysis illustrates the importance of documenting the limitations of the data. The authors found a significant negative attentional bias with an average standardized effect size of 0.26, but they noted that the effect size may have been underestimated due to statistical limitations and that more data were needed to confirm moderator effects [3]. The matrix provides the documentation needed to identify these limitations and to report them accurately. ## Professional Escalation Criteria for Multi-Assay Control Failures ### When to Stop and Seek Help A single control failure in a single assay may be a random event that is resolved by repeating the assay. Repeated control failures across multiple assays indicate a systemic problem that requires investigation. The following situations warrant escalation to a supervisor, a laboratory manager, or a subject matter expert: - The same control fails in two consecutive batches across multiple assays - Multiple controls fail in the same batch across different assays - Control results show a consistent trend toward the failure threshold across assays - A control failure is accompanied by unexpected results in experimental samples - The cause of a control failure cannot be identified after basic troubleshooting ### What to Bring to the Escalation When escalating a control problem, bring the complete control decision matrix and the records for the affected batches. The matrix shows which assays are affected and which are not. The records show the control identities, the expected and observed results, the reagent lot numbers, the instrument calibration records, and the operator notes. The more complete the documentation, the faster the problem can be diagnosed. ### Publication and Reporting Responsibilities When control problems affect published results, the issues must be disclosed. The Committee on Publication Ethics Core Practices address the responsibilities of authors to report their methods accurately and to correct the record when errors are identified [8]. If a control failure is discovered after publication, the authors should contact the journal to discuss a correction or retraction. The control decision matrix supports this disclosure by providing the documentation needed to describe the control strategy and the control results accurately. The matrix also supports the identification of limitations that must be reported in the publication. ## Frequently Asked Questions ### Why do I need both a positive and a negative control? The two controls answer different questions. The positive control confirms that your assay can detect the effect you are studying. The negative control confirms that your assay does not produce the effect on its own. Without both, you cannot distinguish between a true treatment effect and a failure of the assay system. ### Can I use the same control for different experiments? A control validated for one assay may not be valid for another assay. The control must produce the expected effect in the specific assay you are running. A positive control for a PCR assay may not work as a positive control for an ELISA because the two assays detect different things. ### How many control replicates do I need? The number of control replicates depends on the variability of the assay and the cost of the controls. The controls should be replicated enough to detect a problem when it occurs. A single control well may not detect a problem that affects only part of a plate, while a single control animal may not detect contamination that affects only one pen. ### What should I do when my positive control fails? Stop the assay and do not interpret the experimental results. The positive control failure means the assay could not detect the effect, so negative results from experimental samples are not meaningful. Troubleshoot the assay by checking reagents, instruments, and procedures, then repeat the batch with fresh controls. ### What should I do when my negative control produces a signal? Stop the assay and investigate the source of the signal. A negative control that produces a signal indicates contamination, nonspecific binding, or an unintended active ingredient. Identify the source before repeating the assay, because repeating without identifying the cause will likely produce the same problem. ### How do I validate a new control before using it in experiments? Confirm the expected result independently before using the control in experiments. For a positive control, verify that the material produces the expected effect using a different method or a previously validated assay. For a negative control, verify that the material does not produce the effect under the conditions of your assay. ### Do controls need to be included in the statistical analysis? Controls are used to validate the assay and to establish baseline conditions. The statistical analysis of treatment effects typically compares experimental groups to each other and to the negative control baseline. The control data should be reported so that readers can evaluate whether the assay was working during the experimental period. ### How do I document controls for publication? Report the controls in the methods section, including what they were, how they were prepared, and how they were validated. Reporting guidelines available through the EQUATOR Network can help you identify what information to include for your study type [5]. Complete reporting allows other researchers to evaluate and replicate your work. ## Related Diagnostic Guides - [Positive and Negative Controls in Diagnostic Assays: Selection and Interpretation](/knowledge/diagnostics/emerging-tech/positive-and-negative-controls-in-diagnostic-assays-selection-and-interpretation) - [Animal Biology](/blog/guides/animal-biology) - [Animal Research](/blog/guides/animal-research) ## References and Further Reading [1] [Demonstration of Anaplasma marginale transmission to cattle through the intra-transstadial and by unfed larvae of Rhipicephalus microplus routes, with subsequent calculation of infection rates.](https://doi.org/10.1007/s11250-026-05124-4). 2026. [2] [Emotional Responses and Emotion Regulation in Drug-Free Women with Major Depressive Disorder.](https://doi.org/10.29399/npa.29151). 2026. [3] [Attentional bias in paranoia: systematic review and meta-analysis.](https://doi.org/10.1192/bjo.2026.10993). 2026. [4] [NIH Grants and Funding](https://grants.nih.gov/). National Institutes of Health. [5] [EQUATOR Network](https://www.equator-network.org/). EQUATOR Network. [6] [Data Management and Sharing Policy](https://sharing.nih.gov/data-management-and-sharing-policy). National Institutes of Health. [7] [Laboratory Biosafety Manual](https://www.who.int/publications/i/item/9789240011311). World Health Organization. [8] [Core Practices](https://publicationethics.org/core-practices). Committee on Publication Ethics. > This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.